Chemoinformaics analysis of Tetradecyl isobutyrate
| Molecular Weight | 284.484 | nRot | 14 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 1 |
| Exact Molecular Weight | 284.272 | nRing | 0 |
| Solubility: LogS | -6.82 | nHRing | 0 |
| Solubility: LogP | 7.439 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.6685 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.294 |
| Synth | 1.905 |
| Natural Product Likeliness | 0.283 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.754 |
| MDCK | 0.0000153 |
| BBB | 0.193 |
| PPB | 0.975897 |
| VDSS | 1.731 |
| FU | 0.020636 |
| CYP1A2-inh | 0.314 |
| CYP1A2-sub | 0.203 |
| CYP2c19-inh | 0.471 |
| CYP2c19-sub | 0.112 |
| CYP2c9-inh | 0.222 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.134 |
| CYP2d6-sub | 0.069 |
| CYP3a4-inh | 0.312 |
| CYP3a4-sub | 0.101 |
| CL | 4.336 |
| T12 | 0.128 |
| hERG | 0.25 |
| Ames | 0.004 |
| ROA | 0.038 |
| SkinSen | 0.936 |
| Carcinogencity | 0.065 |
| EI | 0.981 |
| Respiratory | 0.768 |
| NR-Aromatase | 0.075 |
| Antiviral | Yes |
| Prediction | 0.640911 |